Home » Topics » BioWorld

BioWorld
RSS

APPOINTMENTS AND ADVANCEMENTS

May 21, 1991

JOURNAL SCAN CLONED GENE MAY HELP ASSESS DIOXIN RISK

May 21, 1991

NEWS BRIEFS

May 21, 1991

SARCOMA PATIENTS RESPOND TO GM-CSF

May 21, 1991

FILDES JOINS START-UP TARGETING NERVE DAMAGE

May 21, 1991

JOURNAL SCAN SERAGEN'S FUSION TOXIN SHOWS EFFICACY

May 20, 1991

GI REVISES QUARTERLY EARNINGS

May 20, 1991

APPOINTMENTS AND ADVANCEMENTS

May 20, 1991

BURROUGHS COUNTERSUES OVER AZT

May 20, 1991

ONCOTECH IDs CANCERS LIKELY TO RESPOND TO DRUGS

May 20, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...